Evaluation of Text Message Engagement Support of Mindfulness Smartphone Applications
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of this study is to assess the usability of two mindfulness smartphone applications (apps) and to evaluate whether text message support can promote engagement with those apps through a 4-week trial comparing support vs. no support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Jun 2018
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2018
CompletedStudy Start
First participant enrolled
June 26, 2018
CompletedFirst Posted
Study publicly available on registry
August 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedJuly 2, 2021
July 1, 2021
2 years
June 26, 2018
July 1, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Depression and Anxiety at Week 2 and Week 4
Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a 9-item self-report measure of depression. Scores on this measure range from 0 (Not At All) to 3 (Nearly Every Day).
Baseline, Week 2, Week 4
Change in Anxiety at Week 2 and Week 4
Generalized Anxiety Disorder 7-item scale (GAD-7). The GAD-7 is a 7-item self-report measure of anxiety. Scores on this measure range from 0 (Not At All) to 3 (Nearly Every Day).
Baseline, Week 2, Week 4
Secondary Outcomes (2)
App Usage
Week 1, Week 2, Week 3, Week 4
App Satisfaction
Week 1, Week 2, Week 3, Week 4
Other Outcomes (7)
Change in Mindfulness at Week 4
Baseline and Week 4
Change in Psychological Flexibility at Week 2 and Week 4
Baseline, Week 2, Week 4
Change in Depression, Anxiety, and Stress at Week 1, 2, 3, and 4
Baseline, Week 1, Week 2, Week 3, Week 4
- +4 more other outcomes
Study Arms (2)
Engagement Support
EXPERIMENTALIn the engagement support group, participants will be sent text messages that will encourage use of the app through tips, reminders, and encouraging messages.
No Engagement Support
OTHERParticipants in this group will receive no text message support.
Interventions
Participants randomized to this arm will receive 1-month full access to the Headspace meditation app. They will be asked to listen to at least one meditation a day over the four week study period. Mindfulness is the ability to intentionally and nonjudgementally observe thoughts, bodily sensations, or feelings in the present moment. The apps include guided mindfulness meditations targeting several different areas, such as stress, anxiety, compassion, and sleep.
Participants randomized to this arm will receive 1-month full access to the Stop, Breathe, \& Think meditation app. They will be asked to listen to at least one meditation a day over the four week study period. Mindfulness is the ability to intentionally and nonjudgementally observe thoughts, bodily sensations, or feelings in the present moment. The apps include guided mindfulness meditations targeting several different areas, such as stress, anxiety, compassion, and sleep.
Eligibility Criteria
You may qualify if:
- meet criteria for clinically significant distress caused by anxiety defined by a Generalized Anxiety Disorder-7 (GAD-7) greater than a 10 or clinically significant distress caused my depression defined by a Patient Health Questionnaire (PHQ-9) greater than 10
- years of age or older;
- fluent in English;
- lives in the Chicago area and are able to attend and in person session;
- own an internet ready smartphone with data and text plans.
You may not qualify if:
- have visual, hearing, voice, or motor impairment that would prevent completion treatment procedures;
- past or current diagnosis of a psychotic disorder, bipolar disorder, dissociative disorder, substance or alcohol abuse dependence, or other diagnosis for which participation in the trial would be dangerous;
- suicidal, defined as a 1 or higher on item 9 of the Patient Health Questionnaire (PHQ-9);
- adults unable to consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwester University, Feinberg School of Medicine, Center for Behavioral Intervention Technologies
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adjunct Assistant Professor
Study Record Dates
First Submitted
June 26, 2018
First Posted
August 16, 2018
Study Start
June 26, 2018
Primary Completion
July 1, 2020
Study Completion
August 1, 2020
Last Updated
July 2, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available.